Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Opko Health, Inc. (NASDAQ: OPK).

Full DD Report for OPK

You must become a subscriber to view this report.


Recent News from (NASDAQ: OPK)

OPK LOSS NOTICE: Rosen Law Firm Reminds OPKO Health, Inc. Investors of Important Deadline in First Filed Case by Firm
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of OPKO Health, Inc. (NASDAQ: OPK) from September 26, 2013 through September 7, 2018, inclusive (the “Class Period”) of the important November 13, 2018 lead plaintiff deadline in the first f...
Source: Business Wire
Date: September, 13 2018 19:42
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of OPKO Health, Inc. Investors
Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ:  OPK ) securities ...
Source: Business Wire
Date: September, 13 2018 18:00
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of OPKO Health, Inc. Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ:  OPK ) securities between  September 26, 20...
Source: Business Wire
Date: September, 13 2018 13:36
Your Daily Scoop: Foamix Zooms, Pfizer And Merck Report Positive
Stocks in News: FOMX, PFE Foamix Pharma +54% as acne drug meets goals in late-stage trial Share price of Foamix Pharmaceuticals ( FOMX ) had a 54.4% spike on September 11 after-hours on the news of positive topline results of third Phase 3 clinical trial of its FMX101 drug. The candida...
Source: SeekingAlpha
Date: September, 13 2018 13:22
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OPKO Health, Inc. (OPK) & Lead Plaintiff Deadline: November 13, 2018
NEW YORK , Sept. 13, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against OPKO Health, Inc. ("OPKO" or the "Company) (NASDAQ: OPK) and certain of its officers, on behalf of shareholders wh...
Source: PR Newswire
Date: September, 13 2018 12:39

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-103.333.323.363.183,106,654
2018-12-073.223.283.423.224,572,538
2018-12-063.483.253.493.186,283,779
2018-12-043.733.493.813.485,455,481
2018-12-033.773.773.833.6854,381,794

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10230,002649,89935.3904Short
2018-12-07360,052780,17146.1504Short
2018-12-06781,6011,578,97749.5005Short
2018-12-04526,076689,87376.2569Short
2018-12-03560,8951,052,57853.2877Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OPK.


About Opko Health, Inc. (NASDAQ: OPK)

Logo for Opko Health, Inc. (NASDAQ: OPK)

Not available

 

Contact Information

 

 

Current Management

  • Adam Logal / Chief Accounting Officer, Treasurer

Current Share Structure

  • Market Cap: $2,232,300,614 - 05/18/2018
  • Issue and Outstanding: 559,473,838 - 05/01/2018

 


Recent Filings from (NASDAQ: OPK)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 06 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018

 

 


Daily Technical Chart for (NASDAQ: OPK)

Daily Technical Chart for (NASDAQ: OPK)


Stay tuned for daily updates and more on (NASDAQ: OPK)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: OPK)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OPK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OPK and does not buy, sell, or trade any shares of OPK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/